Loading clinical trials...
Loading clinical trials...
To examine and to compare the evolution of aqueous flare from presentation until the third postoperative month in a series of consecutive patients who underwent primary vitrectomy for rhegmatogenous retinal detachment (RRD), in 4 groups of patients : * Group 1 : 48 eyes primarily treated with gas tamponade * Group 2 : 11 eyes primarily treated with silicone oil tamponade * Sub-Group G1RG : 8 eyes among Group 1 treated with gas after relapse * Sub-Group G1RS : 3 eyes among Group 1 treated with silicone oil after relapse
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
BERROD Jean-Paul MD
Nancy, Grand Est, France
Start Date
June 3, 2020
Primary Completion Date
June 4, 2021
Completion Date
June 4, 2021
Last Updated
September 22, 2021
48
ACTUAL participants
Aqueous flare measurement
OTHER
Lead Sponsor
Central Hospital, Nancy, France
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05331664